Suchergebnisse - "Aparna, A"

PubPharm (7)

1

Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer

enthalten in: The Lancet. Oncology | 2011

von Coleman, R. | Duska, L. | Ramirez, P. | +12

CommentIn: Lancet Oncol. 2011 Nov;12(12):1082-3. - PMID 21992854

2

Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer

enthalten in: Cancer biology & therapy | 2010

von Merritt, W. | Kamat, A. | Hwang, J. | +16

3

Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2008

von Lin, Y. | Immaneni, A. | Merritt, W. | +17

4

Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth

enthalten in: Journal of the National Cancer Institute | 2008

von Merritt, W. | Lin, Y. | Spannuth, W. | +13

5

Clinical and biological significance of vascular endothelial growth factor in endometrial cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2007

von Kamat, A. | Merritt, W. | Coffey, D. | +11

6

Antitumor and antivascular effects of AVE8062 in ovarian carcinoma

enthalten in: Cancer research | 2007

von Kim, T. | Ravoori, M. | Landen, C. | +12

7

Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer

enthalten in: Cancer research | 2007

von Kamat, A. | Kim, T. | Landen, C. | +11

ErratumIn: Cancer Res. 2018 Jul 15;78(14):4099. - PMID 30012859

1
[1]